Legal & General Group
TNYA icon

Legal & General Group’s Tenaya Therapeutics TNYA Stock Holding History

Legal & General Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,802
Closed -$3.31K – 3540
2025
Q1 		$3.31K Hold
5,802
– – ﹤0.01% 3324
2024
Q4 		$8.3K Hold
5,802
– – ﹤0.01% 3284
2024
Q3 		$11.2K Buy
5,802
+1,184
+26% +$3.34K ﹤0.01% 3249
2024
Q2 		$14.3K Buy
4,618
+367
+9% +$1.52K ﹤0.01% 3163
2024
Q1 		$22.2K Hold
4,251
– – ﹤0.01% 2922
2023
Q4 		$13.8K Hold
4,251
– – ﹤0.01% 3167
2023
Q3 		$10.8K Hold
4,251
– – ﹤0.01% 3252
2023
Q2 		$25K Hold
4,251
– – ﹤0.01% 3017
2023
Q1 		$12.1K Buy
4,251
+1,941
+84% +$5.45K ﹤0.01% 3175
2022
Q4 		$4.63K Hold
2,310
– – ﹤0.01% 3352
2022
Q3 		$7K Hold
2,310
– – ﹤0.01% 3378
2022
Q2 		$13K Sell
2,310
-427
-16% -$3.46K ﹤0.01% 3341
2022
Q1 		$32K Buy
2,737
+1,432
+110% +$17.3K ﹤0.01% 3109
2021
Q4 		$25K Hold
1,305
– – ﹤0.01% 3203
2021
Q3 		$27K Buy
+1,305
New +$28K ﹤0.01% 3172

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Legal & General Group's TNYA Position: Q2 2025 in Review

Legal & General Group sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 5,802 shares — an estimated $3.31K sold.

Legal & General Group first reported a position in TNYA in Q3 2021 and held it in 15 quarters. The position peaked at $32K in Q1 2022. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • Legal & General Group reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 5,802 Tenaya Therapeutics shares in Q2 2025, an estimated $3.31K.
  • Legal & General Group first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 15 quarters.
  • Legal & General Group's Tenaya Therapeutics position peaked at $32K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.